TY  - GEN
AU  - Nomura,Takeshi
AU  - Shibahara,Takahiko
AU  - Uchiyama,Takeshi
AU  - Yamamoto,Nobuharu
AU  - Shibui,Takeo
AU  - Yakushiji,Takashi
AU  - Watanabe,Akira
AU  - Muramatsu,Kyotaro
AU  - Ogane,Satoshi
AU  - Murayama,Masato
AU  - Sekine,Riyo
AU  - Nakata,Erika
AU  - Fujimoto,Yuko
TI  - Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic
SN  - 0040-8891
PY  - 2015///0406
KW  - Administration, Oral
KW  - Adrenal Cortex Hormones
KW  - therapeutic use
KW  - Aged
KW  - Aged, 80 and over
KW  - Alendronate
KW  - administration & dosage
KW  - Anti-Bacterial Agents
KW  - Arthritis, Rheumatoid
KW  - drug therapy
KW  - Bisphosphonate-Associated Osteonecrosis of the Jaw
KW  - Bone Density Conservation Agents
KW  - Bone Neoplasms
KW  - Breast Neoplasms
KW  - pathology
KW  - Diabetes Complications
KW  - Diphosphonates
KW  - Etidronic Acid
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Imidazoles
KW  - Infusions, Parenteral
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Oral Surgical Procedures
KW  - Osteoporosis
KW  - Prostatic Neoplasms
KW  - Risedronic Acid
KW  - Treatment Outcome
KW  - Wound Healing
KW  - physiology
KW  - Zoledronic Acid
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.2209/tdcpublication.54.117
ER  -